Skip to content

TriVascular Technologies, Inc.

Delisted

CIK 1432732fmd_1RD5WE4DH1D6X2VKQK9JE4M56FManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2012 to Sep 30, 2015, 12 periods

Latest annual · FY2014

Millions
Total revenues
32
Gross profit
18
Operating income
(50)
Net income
(57)
Free cash flow
(54)

Latest quarter · Q3 FY2015

Millions
Total revenues
9
Gross profit
6
Operating income
(11)
Net income
(14)
Free cash flow
(12)
Open Financials

TriVascular Technologies, Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2014FY2013ChangeSource
Revenue$31.8 million$19.5 million+63%10-K 2015-03-09 · proof
Gross profit$18 million$7.8 million+130.5%10-K 2015-03-09 · proof
Operating income-$50 million-$43.9 million10-K 2015-03-09 · proof
Net income-$57.4 million-$50.3 million10-K 2015-03-09 · proof
Cash from operating activities-$53.6 million-$46.9 million10-K 2015-03-09 · proof
Free cash flow-$53.9 million-$47.1 million10-K 2015-03-09 · proof
Total assets$108.5 million$64.7 million+67.7%10-K 2015-03-09 · proof
Total liabilities$69 million$53.5 million+28.9%10-K 2015-03-09 · proof
Cash and cash equivalents$32.9 million$38.1 million-13.7%10-K 2015-03-09 · proof
What was TriVascular Technologies, Inc.'s revenue in fiscal 2014?
TriVascular Technologies, Inc. reported revenue of $31.8 million for fiscal 2014 (the year ended Dec 31, 2014), against $19.5 million the year before (+63%). Source: the 10-K filed with the SEC on Mar 9, 2015. SEC
What was TriVascular Technologies, Inc.'s gross profit in fiscal 2014?
TriVascular Technologies, Inc. reported gross profit of $18 million for fiscal 2014 (the year ended Dec 31, 2014), against $7.8 million the year before (+130.5%). Source: the 10-K filed with the SEC on Mar 9, 2015. SEC
What was TriVascular Technologies, Inc.'s operating income in fiscal 2014?
TriVascular Technologies, Inc. reported operating income of -$50 million for fiscal 2014 (the year ended Dec 31, 2014), against -$43.9 million the year before. Source: the 10-K filed with the SEC on Mar 9, 2015. SEC
What was TriVascular Technologies, Inc.'s net income in fiscal 2014?
TriVascular Technologies, Inc. reported net income of -$57.4 million for fiscal 2014 (the year ended Dec 31, 2014), against -$50.3 million the year before. Source: the 10-K filed with the SEC on Mar 9, 2015. SEC
What was TriVascular Technologies, Inc.'s cash from operating activities in fiscal 2014?
TriVascular Technologies, Inc. reported cash from operating activities of -$53.6 million for fiscal 2014 (the year ended Dec 31, 2014), against -$46.9 million the year before. Source: the 10-K filed with the SEC on Mar 9, 2015. SEC
What was TriVascular Technologies, Inc.'s free cash flow in fiscal 2014?
TriVascular Technologies, Inc. reported free cash flow of -$53.9 million for fiscal 2014 (the year ended Dec 31, 2014), against -$47.1 million the year before. Source: the 10-K filed with the SEC on Mar 9, 2015. SEC
What are TriVascular Technologies, Inc.'s total assets?
As of Dec 31, 2014, TriVascular Technologies, Inc. reported total assets of $108.5 million, against $64.7 million a year earlier (+67.7%). Source: the 10-K filed with the SEC on Mar 9, 2015. SEC
What are TriVascular Technologies, Inc.'s total liabilities?
As of Dec 31, 2014, TriVascular Technologies, Inc. reported total liabilities of $69 million, against $53.5 million a year earlier (+28.9%). Source: the 10-K filed with the SEC on Mar 9, 2015. SEC
What are TriVascular Technologies, Inc.'s cash and cash equivalents?
As of Dec 31, 2014, TriVascular Technologies, Inc. reported cash and cash equivalents of $32.9 million, against $38.1 million a year earlier (-13.7%). Source: the 10-K filed with the SEC on Mar 9, 2015. SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1432732&period_type=annual&limit=5"

Information only, not investment advice.